Despite not demonstrating statistically significant superiority in progression-free survival (PFS) for patients with metastatic colorectal cancer...
The traditional formula for weight loss is simple: induce a negative energy balance by increasing physical activities and reducing caloric intake...
According to the American Cancer Society, approximately 12,000 deaths were caused by multiple myeloma (MM) in 2021. Current drug therapies on the...
The FDA has approved sutimlimab-jome (Enjaymo, Sanofi) to decrease the need for red blood cell transfusion because of hemolysis in adults with co...
Larotrectinib ( Vitrakvi ) is a tyrosine kinase receptor (TRK) inhibitor indicated for the treatment of metastatic or unresectable neurotrophic...
Survival among patients with persistent, recurrent, or metastatic cervical cancer who were receiving chemotherapy with or without bevacizumab (...
The COVID-19 vaccines induced functional T cell and antibody responses when given to patients with chronic lymphocytic leukemia (CLL), providin...
Frontline induction treatment with ibrutinib (Imbruvica) and rituximab (Rituxan) followed by rituximab plus hyper-fractionated cyclophosphami...
The safety profile of evorpacept with or without pembrolizumab ( Keytruda ) or trastuzumab (Herceptin) supports the use of the regimen in pat...
Treatment with frontline maintenance selinexor (Xpovio) after a combination chemotherapy regimen resulted in a significant improvement in progres...